TMCnet News
Research and Markets: Atrial Fibrillation Global Clinical Trials Review, H2 2013 ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/ssmvml/atrial) has announced the addition of the "Atrial Fibrillation Global Clinical Trials Review, H2, 2013" report to their offering. Atrial Fibrillation Global Clinical Trials Review, H2, 2013 provides data on the Atrial Fibrillation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining o the number of trials for the key drugs for treating Atrial Fibrillation. Scope
Top Companies Participating in Atrial Fibrillation Therapeutics Clinical Trials
Clinical Trial Overview of Top Institutes / Government
For more information visit http://www.researchandmarkets.com/research/ssmvml/atrial
|